Related Articles
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma
Identification of Cystatin SN as a novel tumor marker for colorectal cancer
Value of combined detection of serum carcino‑embryonic antigen, carbohydrate antigen 19‑9 and cyclooxygenase‑2 in the diagnosis of colorectal cancer
Combined assays for serum carcinoembryonic antigen and microRNA‑17-3p offer improved diagnostic potential for stage I/II colon cancer
Possible predictive significance of serum RalA autoantibodies on relapse‑free survival in patients with colorectal cancer